Davide Bartoli: The Hidden Cost of Informal Caregiving After Stroke
Davide Bartoli, Researcher at Sapienza University of Rome, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Our new paper is out in European Journal of Cardiovascular Nursing
We explore the hidden cost of informal caregiving after stroke — and why it matters more than we think.
Key insights:
- Informal caregiving significantly affects workforce participation
- There is a measurable impact on caregivers’ quality of life
- The burden falls disproportionately on women
- Ignoring this cost has major economic and policy implications
Caring for caregivers is not just a moral imperative — it’s a societal and economic one.”
Title: The hidden cost of informal care: a commentary on productivity loss, gender inequality, and the invisible workforce of stroke carers
Authors: Davide Bartoli, Gianluca Pucciarelli, Francesco Petrosino
Read the Full Article on European Journal of Cardiovascular Nursing
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 4, 2026, 15:12Rethinking Stroke Prevention – New Frontiers in Minimizing Bleeding Concerns – ISTH
-
Jul 4, 2026, 14:40Liver Cirrhosis and Portal Vein Thrombosis: Understanding a Critical Complication
-
Jul 4, 2026, 14:40Debra Bellon: A Milestone for Global Rare Disease Advocacy in Nairobi
-
Jul 4, 2026, 14:11Erica Wood: Next Webinar from the Optimal Centre of Research Excellence on Improving Immunoglobulin Use
-
Jul 4, 2026, 14:07Ariela Marshall: Optimizing Inpatient Hematology Consult Services Through Best Practices And Strategy
-
Jul 4, 2026, 13:53Azusa Nagao: Why Is von Willebrand Disease Still Being Missed in Japan?
-
Jul 4, 2026, 13:32Jim Hoffman: Lupus Treatment Must Balance Disease Control with Long-Term Safety
-
Jul 4, 2026, 13:16Jim Vadolas: New Evidence Linking Iron Dysregulation to Inflammation in Myelodysplastic Syndromes
-
Jul 4, 2026, 12:47Panagiota Tsiatsiou: Tissue Factor Biomarkers Reveal Persistent Procoagulant Activity During Combined Androgen Blockade in Prostate Cancer